Related Experiment Videos
An antineuronal autoantibody in paraneoplastic opsoclonus.
C Budde-Steffen1, N E Anderson, M K Rosenblum
1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Annals of Neurology
|May 1, 1988
Summary
Researchers identified a novel antineuronal nuclear antibody in a patient with paraneoplastic opsoclonus, breast cancer, and ataxia. This specific antibody was not detected in other paraneoplastic opsoclonus cases studied.
Area of Science:
- Neurology
- Immunology
- Oncology
Background:
- Paraneoplastic opsoclonus is a rare neurological disorder often associated with underlying malignancy.
- Identifying specific autoantibodies is crucial for understanding the pathogenesis and improving diagnosis of paraneoplastic syndromes.
Purpose of the Study:
- To investigate the presence and characteristics of antineuronal autoantibodies in patients with paraneoplastic opsoclonus.
Main Methods:
- Serum samples from 7 patients diagnosed with paraneoplastic opsoclonus were analyzed for antineuronal autoantibodies.
- Immunoblotting techniques were employed to identify specific antigens recognized by detected antibodies.
Main Results:
- An antibody targeting neuronal nuclei was identified in the serum of one patient who presented with breast cancer, opsoclonus, and ataxia.
- This autoantibody recognized antigens of approximately 53-61 kDa and 79-84 kDa in neuronal immunoblots.
- No antineuronal antibodies were detected in the serum of the remaining 6 patients with paraneoplastic opsoclonus.
Conclusions:
- A specific antineuronal nuclear antibody associated with breast cancer, opsoclonus, and ataxia has been identified.
- This finding suggests a potential role for this antibody in the pathogenesis of this specific paraneoplastic syndrome.
- Further research is warranted to elucidate the clinical significance and prevalence of this antibody in paraneoplastic opsoclonus.